Retrospective Study on Characteristics and Outcomes in Hospitalised Patients Treated With Ondexxya

Launched by ASTRAZENECA · Jun 1, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at patients who have been hospitalized and treated with a medication called andexanet alfa, which is used to help stop bleeding in people who are on blood thinners. The study is taking place in about 10 hospitals in the Netherlands and aims to gather more information about the types of patients who receive this treatment and what their outcomes are after using it. This information is important because it can help doctors understand how best to use andexanet alfa in their practice.

To be eligible for this study, participants need to be at least 18 years old and must have received at least one dose of andexanet alfa while in the hospital. There are no specific health conditions that would exclude someone from joining. If you or a family member are part of this study, you can expect that researchers will review medical records to learn more about your treatment and recovery, which will help improve care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years
• • Received at least one dose of andexanet alfa
• Exclusion Criteria:
• • None